Vimarsana
Biggest News Aggregation in the World

Page 4 - Cellular Immune News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Cellular Immune. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Cellular Immune Today - Breaking & Trending Today

Emmes offers support for Moderna's Covid-19 vaccine trial in Africa - Vimarsana News

Emmes offers support for Moderna's Covid-19 vaccine trial in Africa

Emmes has announced plans to offer data, statistical analysis and project management support for Moderna’s Covid-19 vaccine trial in Africa.

Smartphone app could screen for neurological disease at home - Vimarsana News

Smartphone app could screen for neurological disease at home

University of California researchers have developed an app that uses a near-infrared camera to check for neurological disease.

Catalyst acquires Aptus Clinical to expedite expansion to Europe - Vimarsana News

Catalyst acquires Aptus Clinical to expedite expansion to Europe

Catalyst Clinical Research acquired Aptus Clinical for expediting expansion to Europe, widening client services and improving patient impact.

Alterity receives MHRA authorisation for Phase II trial of MSA therapy - Vimarsana News

Alterity receives MHRA authorisation for Phase II trial of MSA therapy

Alterity Therapeutics has received the MHRA acceptance for its request to proceed with Phase II trial of ATH434 in MSA.

UT Health San Antonio to study antibiotics for gum disease treatment - Vimarsana News

UT Health San Antonio to study antibiotics for gum disease treatment

The UT Health San Antonio has received a four-year award of $2.4m from the NIH to study usage of antibiotics for periodontal disease.